RYGB outperforms drugs, gastrectomy in lowering A1C

02/26/2013 | MedPage Today (free registration)

Roux-en-Y gastric-bypass surgery fared better than sleeve gastrectomy and optimal medical therapy in reducing A1C levels and boosting insulin sensitivity and beta-cell function in patients with diabetes, according to a study in Diabetes Care. "Gastric bypass essentially was like CPR to a failing pancreas. It was able to restore its function, and this led to durable blood sugar control for these patients," said researcher Dr. Sangeeta R. Kashyap.

View Full Article in:

MedPage Today (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Paralegal
Mylan Inc.
Washington, DC
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA